Krystal Biotech, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the annual meeting of stockholders held on May 29, 2020. Krystal Biotech, Inc. (KRYS) is a Delaware corporation trading on the Nasdaq and is classified as an emerging growth company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes
No material financial changes are reported in this filing. The document details the successful election of directors and the ratification of the independent auditor.
Management Commentary and Voting Results
Two matters were submitted to a vote of security holders:
- Election of Class III Directors: Two directors were elected for a term expiring at the 2023 annual meeting.
- Ratification of Auditor: The selection of Mayer Hoffman McCann P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2020, was ratified.
| Director Candidate | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| Krish Krishnan | 11,462,445 | 863,609 | 2,984,339 |
| Kirti Ganorkar | 11,476,518 | 849,536 | 2,984,339 |
| Proposal | Votes For | Votes Against | Abstentions |
|---|---|---|---|
| Ratification of Auditor | 15,297,662 | 4,976 | 7,755 |
Key Facts for Investor Verification
- Confirm the term expiration dates for the newly elected Class III directors (2023).
- Verify the engagement of Mayer Hoffman McCann P.C. for the 2020 fiscal year audit.
- Note the significant number of broker non-votes (approx. 2.98 million) regarding the director elections.
- Review subsequent filings (10-Q or 10-K) for financial performance data, as this 8-K contains no financial metrics.